» Articles » PMID: 36970895

Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline

Abstract

Background: Preclinical Alzheimer's disease (AD) is one possible cause of subjective cognitive decline (SCD). Normal task performance despite ongoing neurodegeneration is typically considered as neuronal compensation, which is reflected by greater neuronal activity. Compensatory brain activity has been observed in frontal as well as parietal regions in SCD, but data are scarce, especially outside the memory domain.

Objective: To investigate potential compensatory activity in SCD. Such compensatory activity is particularly expected in participants where blood-based biomarkers indicated amyloid positivity as this implies preclinical AD.

Methods: 52 participants with SCD (mean age: 71.00±5.70) underwent structural and functional neuroimaging (fMRI), targeting episodic memory and spatial abilities, and a neuropsychological assessment. The estimation of amyloid positivity was based on plasma amyloid-β and phosphorylated tau (pTau181) measures.

Results: Our fMRI analyses of the spatial abilities task did not indicate compensation, with only three voxels exceeding an uncorrected threshold at p < 0.001. This finding was not replicated in a subset of 23 biomarker positive individuals.

Conclusion: Our results do not provide conclusive evidence for compensatory brain activity in SCD. It is possible that neuronal compensation does not manifest at such an early stage as SCD. Alternatively, it is possible that our sample size was too small or that compensatory activity may be too heterogeneous to be detected by group-level statistics. Interventions based on the individual fMRI signal should therefore be explored.

Citing Articles

Research progress on brain network imaging biomarkers of subjective cognitive decline.

Yingmei H, Chaojie W, Yi Z, Yijie L, Heng Z, Ze F Front Neurosci. 2025; 19:1503955.

PMID: 40018359 PMC: 11865231. DOI: 10.3389/fnins.2025.1503955.


Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review.

Mitolo M, Lombardi G, Manca R, Nacmias B, Venneri A J Neurol. 2024; 271(11):7120-7140.

PMID: 39264441 PMC: 11560990. DOI: 10.1007/s00415-024-12674-w.


Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease.

Colavitta M, Barrantes F Pharmaceutics. 2023; 15(8).

PMID: 37631266 PMC: 10459958. DOI: 10.3390/pharmaceutics15082052.

References
1.
Hao L, Xing Y, Li X, Mu B, Zhao W, Wang G . Risk Factors and Neuropsychological Assessments of Subjective Cognitive Decline () in Chinese Memory Clinic. Front Neurosci. 2019; 13:846. PMC: 6702310. DOI: 10.3389/fnins.2019.00846. View

2.
Kloppel S, Vongerichten A, van Eimeren T, Frackowiak R, Siebner H . Can left-handedness be switched? Insights from an early switch of handwriting. J Neurosci. 2007; 27(29):7847-53. PMC: 6672868. DOI: 10.1523/JNEUROSCI.1299-07.2007. View

3.
Amariglio R, Mormino E, Pietras A, Marshall G, Vannini P, Johnson K . Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly. Neurology. 2015; 85(1):56-62. PMC: 4501939. DOI: 10.1212/WNL.0000000000001712. View

4.
Koppara A, Wagner M, Lange C, Ernst A, Wiese B, Konig H . Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimers Dement (Amst). 2016; 1(2):194-205. PMC: 4876897. DOI: 10.1016/j.dadm.2015.02.005. View

5.
Seydell-Greenwald A, Ferrara K, Chambers C, Newport E, Landau B . Bilateral parietal activations for complex visual-spatial functions: Evidence from a visual-spatial construction task. Neuropsychologia. 2017; 106:194-206. PMC: 6408728. DOI: 10.1016/j.neuropsychologia.2017.10.005. View